Whole-exome sequencing analysis of esophageal cancer cells with AHNAK2 knockdown revealed that AHNAK2 may act through NF-κB and TNF signaling pathways to regulate the expression of interleukins, interleukin receptors and chemokines (87). Here, AHNAK2 is linked to esophageal cancer.